Jane Street Group, LLC Ionis Pharmaceuticals Inc Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 176,560 shares of IONS stock, worth $6.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

176,560

Previous 179,246 1.5%

Holding current value

$6.24 Million

Previous $8.54 Million 17.21%

% of portfolio

0.0%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$40.06 - $51.86 $107,601 - $139,295	-2,686 Reduced 1.5%	176,560 $7.07 Million
Q2 2024 Aug 14, 2024	BUY	$36.45 - $47.7 $2.23 Million - $2.92 Million	61,114 Added 51.73%	179,246 $8.54 Million
Q1 2024 May 15, 2024	SELL	$42.03 - $53.55 $1.51 Million - $1.93 Million	-36,032 Reduced 23.37%	118,132 $5.12 Million
Q4 2023 Feb 14, 2024	SELL	$43.39 - $51.63 $4.31 Million - $5.13 Million	-99,327 Reduced 39.18%	154,164 $7.8 Million
Q3 2023 Nov 14, 2023	BUY	$38.5 - $47.13 $5.59 Million - $6.84 Million	145,167 Added 134.01%	253,491 $11.5 Million
Q2 2023 Aug 14, 2023	BUY	$34.73 - $43.33 $153,610 - $191,648	4,423 Added 4.26%	108,324 $4.44 Million
Q1 2023 May 15, 2023	BUY	$33.58 - $41.2 $3.1 Million - $3.81 Million	92,421 Added 805.06%	103,901 $3.71 Million
Q4 2022 Feb 14, 2023	SELL	$37.12 - $46.52 $339,610 - $425,611	-9,149 Reduced 44.35%	11,480 $433,000
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $2.57 Million - $3.42 Million	-70,260 Reduced 77.3%	20,629 $913,000
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $2.57 Million - $3.42 Million	-70,260 Reduced 77.3%	20,629 $913,000
Q2 2022 Aug 16, 2022	BUY	$31.71 - $43.0 $2 Million - $2.71 Million	63,098 Added 227.04%	90,889 $3.36 Million
Q1 2022 May 17, 2022	SELL	$29.88 - $37.04 $739,798 - $917,073	-24,759 Reduced 47.12%	27,791 $1.03 Million
Q4 2021 Feb 15, 2022	SELL	$25.61 - $35.1 $305,424 - $418,602	-11,926 Reduced 18.5%	52,550 $1.6 Million
Q3 2021 Nov 16, 2021	BUY	$33.54 - $40.55 $605,698 - $732,292	18,059 Added 38.91%	64,476 $2.16 Million
Q2 2021 Aug 16, 2021	BUY	$34.54 - $47.25 $468,155 - $640,426	13,554 Added 41.24%	46,417 $1.85 Million
Q1 2021 May 18, 2021	SELL	$42.51 - $63.78 $2.03 Million - $3.05 Million	-47,779 Reduced 59.25%	32,863 $1.48 Million
Q4 2020 Feb 17, 2021	BUY	$45.3 - $60.27 $69,127 - $91,972	1,526 Added 1.93%	80,642 $4.56 Million
Q3 2020 Nov 17, 2020	BUY	$47.45 - $62.95 $2.29 Million - $3.03 Million	48,190 Added 155.82%	79,116 $3.75 Million
Q2 2020 Aug 17, 2020	BUY	$46.85 - $61.05 $1.05 Million - $1.37 Million	22,450 Added 264.87%	30,926 $1.82 Million
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $1.44 Million - $2.19 Million	-34,617 Reduced 80.33%	8,476 $401,000
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $2.12 Million - $2.57 Million	39,343 Added 1049.15%	43,093 $2.6 Million
Q3 2019 Nov 14, 2019	SELL	$59.06 - $72.15 $369,538 - $451,442	-6,257 Reduced 62.53%	3,750 $225,000
Q2 2019 Aug 15, 2019	BUY	$62.09 - $86.14 $57,433 - $79,679	925 Added 10.18%	10,007 $643,000
Q1 2019 May 16, 2019	SELL	$52.92 - $81.17 $1.42 Million - $2.18 Million	-26,846 Reduced 74.72%	9,082 $737,000
Q4 2018 Feb 15, 2019	SELL	$43.37 - $59.54 $260,133 - $357,120	-5,998 Reduced 14.31%	35,928 $1.94 Million
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $1.8 Million - $2.25 Million	41,926 New	41,926 $2.16 Million
Q2 2018 Aug 15, 2018	SELL	$40.53 - $50.7 $775,865 - $970,550	-19,143 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $383,011 - $478,329	8,689 Added 83.12%	19,143 $844,000
Q4 2017 Feb 15, 2018	BUY	$50.3 - $64.39 $525,836 - $673,133	10,454	10,454 $526,000

Others Institutions Holding IONS

# of Institutions

404

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.02B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Ionis Pharmaceuticals Inc Transaction History